Cryo-EM structure of the transposon-associated TnpB enzyme
Nature · 13.04.2023 · 616 (7956) · 390-397
DOI: 10.1038/s41586-023-05933-9 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nature, online erschienen am 05.04.2023. Verfasst von Ryoya Nakagawa und 21 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biological Sciences, Graduate School of Science, The University of Tokyo, Tokyo, Japan. Hauptthemen laut MEDLINE: Bacterial Proteins, Cryoelectron Microscopy, DNA Transposable Elements, Endodeoxyribonucleases. Die Arbeit wurde bisher 113-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NHGRI NIH HHS, NIGMS NIH HHS.
Abstract (Originalsprache)
The class 2 type V CRISPR effector Cas12 is thought to have evolved from the IS200/IS605 superfamily of transposon-associated TnpB proteins 1 . Recent studies have identified TnpB proteins as miniature RNA-guided DNA endonucleases 2,3 . TnpB associates with a single, long RNA (ωRNA) and cleaves double-stranded DNA targets complementary to the ωRNA guide. However, the RNA-guided DNA cleavage mechanism of TnpB and its evolutionary relationship with Cas12 enzymes remain unknown. Here we report the cryo-electron microscopy (cryo-EM) structure of Deinococcus radiodurans ISDra2 TnpB in complex with its cognate ωRNA and target DNA. In the structure, the ωRNA adopts an unexpected architecture and forms a pseudoknot, which is conserved among all guide RNAs of Cas12 enzymes. Furthermore, the structure, along with our functional analysis, reveals how the compact TnpB recognizes the ωRNA and cleaves target DNA complementary to the guide. A structural comparison of TnpB with Cas12 enzymes suggests that CRISPR–Cas12 effectors acquired an ability to recognize the protospacer-adjacent motif-distal end of the guide RNA–target DNA heteroduplex, by either asymmetric dimer formation or diverse REC2 insertions, enabling engagement in CRISPR–Cas adaptive immunity. Collectively, our findings provide mechanistic insights into TnpB function and advance our understanding of the evolution from transposon-encoded TnpB proteins to CRISPR–Cas12 effectors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Biological Sciences, Graduate School of Science, The University of Tokyo, Tokyo, Japan.
- Broad Institute of MIT and Harvard, Cambridge, MA, USA.
- McGovern Institute for Brain Research at MIT, Massachusetts Institute of Technology, Cambridge, MA, USA.
- Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA.
- Department of Brain and Cognitive Science, Massachusetts Institute of Technology, Cambridge, MA, USA.
- Howard Hughes Medical Institute, Cambridge, MA, USA.
Förderung
- NHGRI NIH HHS
- NIGMS NIH HHS
Zitieren
APA
Nakagawa, R., Hirano, H., Omura, S. N., Nety, S., Kannan, S., Altae-Tran, H., Yao, X., Sakaguchi, Y., Ohira, T., Wu, W. Y., Nakayama, H., Shuto, Y., Tanaka, T., Sano, F. K., Kusakizako, T., Kise, Y., Itoh, Y., Dohmae, N., van der Oost, J., …, & Nureki, O. (2023). Cryo-EM structure of the transposon-associated TnpB enzyme. Nature, 616(7956), 390-397. https://doi.org/10.1038/s41586-023-05933-9
Vancouver
Nakagawa R, Hirano H, Omura SN, Nety S, Kannan S, Altae-Tran H, et al. Cryo-EM structure of the transposon-associated TnpB enzyme. Nature. 2023;616(7956):390-397. doi:10.1038/s41586-023-05933-9
BibTeX
@article{Nakagawa2023,
author = {Nakagawa, Ryoya and Hirano, Hisato and Omura, Satoshi N and Nety, Suchita and Kannan, Soumya and Altae-Tran, Han and Yao, Xiao and Sakaguchi, Yuriko and Ohira, Takayuki and Wu, Wen Y and Nakayama, Hiroshi and Shuto, Yutaro and Tanaka, Tatsuki and Sano, Fumiya K and Kusakizako, Tsukasa and Kise, Yoshiaki and Itoh, Yuzuru and Dohmae, Naoshi and van der Oost, John and Suzuki, Tsutomu and Zhang, Feng and Nureki, Osamu},
title = {Cryo-EM structure of the transposon-associated TnpB enzyme},
journal = {Nature},
year = {2023},
volume = {616},
number = {7956},
pages = {390--397},
doi = {10.1038/s41586-023-05933-9}
}
EUVIMED